RBC Capital Maintains Outperform on WELL Health Technologies, Raises Price Target to C$8.5

Benzinga · 01/07 15:27
RBC Capital analyst Douglas Miehm maintains WELL Health Technologies (TSX:WELL) with a Outperform and raises the price target from C$7 to C$8.5.